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RIP keratinocytes
Epidermal keratinocytes not only function in the formation of 
a stratified epidermis but also are critical for the regulation of 
immune responses in the skin. Deregulation of keratinocyte 
responses may therefore underlie inflammatory skin diseases. The 
Fas-associated death domain (FADD) adaptor protein functions 
in the tumor necrosis factor family pathway to induce apopto-
sis. Recently, death receptors have been shown to induce pro-
grammed necrosis or necroptosis via RIP1/RIP3 kinases. Bonnet 
and colleagues demonstrated that epidermis-specific ablation of 
FADD results in spontaneous necrosis of keratinocytes and severe 
inflammatory skin disease in mice. Interestingly, deletion of RIP3 
ablated the keratinocyte necrosis and inflammatory skin lesions 
that resulted from FADD deficiency. RIP3-dependent necrosis of 
FADD-deficient keratinocytes is therefore a triggering event for 
the severe skin inflammation observed in FADD knockout mice. 
Thus, FADD performs a critical prosurvival function in kerati-
nocytes to ensure skin immune homeostasis and prevent skin 
inflammation. (Immunity 35:572–82, 2011) Selected by T. Krieg
Improving pigment
Oculocutaneous albinism type 1 (OCA1), which stems from 
mutations in the tyrosinase gene (TYR), involves reduced pig-
mentation phenotypes, including loss of vision. Onojafe and 
colleagues recently examined the effects of treatment with nitisi-
none, an inhibitor of an upstream tyrosine catabolism enzyme, 
on pigmentation in an OCA mouse model. This drug, which has 
received approval from the US Food and Drug Administration for 
treatment of hereditary tyrosinemia type 1, results in increased 
plasma tyrosine levels in treated patients. Indeed, nitisinone 
treatment increased ocular and cutaneous pigmentation in mice 
with mutant but active tyrosinase. The concomitant increased 
tyrosine levels stabilized the mutant tyrosinase in these mice and 
allowed maximum residual enzymatic activity and pigment pro-
duction. Similar results were obtained in melanocytes cultured 
from an OCA-1B patient, suggesting clinical relevance for these 
findings. Although nitisinone increases ocular pigment produc-
tion, whether this pigment translates to improved visual function 
remains to be determined. (J Clin Invest 121:3914–23, 2011) 
Selected by T. Schwarz
Stay-at-home T cells
Cutaneous T-cell lymphomas (CTCLs) are malignancies of 
skin-homing T cells and include skin-limited mycosis fungoi-
des (MF) and leukemic forms of the disease (L-CTCL). Clark 
and colleagues recently reported that low-dose alemtuzumab 
(Campath), a humanized T cell–depleting monoclonal antibody 
directed against CD52, induces clinical responses in 100% and 
clinical remissions in 50% of patients with refractory L-CTCL. 
Malignant T cells have a central memory (Tcm) phenotype 
in L-CTCL and an effector memory (Tem) phenotype in MF. 
Treatment with alemtuzumab depleted T cells in the blood but 
not in the skin, effectively treating L-CTCL but not MF. This treat-
ment selectively depleted the skin of all Tcm cells whereas a 
diverse population of skin-resident Tem cells remained intact. 
These results suggest that Tcm cells actively recirculate between 
the blood and the skin and that Tem cells are nonrecirculating 
skin-resident cells. Importantly, these resident Tem cells offered 
patients robust protection against infection, supporting alemtu-
zumab treatment for L-CTCL. (Sci Transl Med 4:117ra7, 2012) 
Selected by L. Beck
Tumorigenic scavengers
Modi and colleagues recently utilized the two-stage cutaneous 
chemical carcinogenesis model that involves application of the 
initiator polyaromatic hydrocarbon (PAH) DMBA followed by 
the tumor promoter TPA to induce papillomas, which some-
times develop into squamous cell carcinomas, to investigate 
the role of skin-resident immune cells to protect against car-
cinogenesis. Langerhans cell (LC)–deficient mice were nearly 
completely resistant to DMBA-TPA-induced carcinogenesis in 
a T cell–independent manner. LC-deficient skin was resistant to 
DMBA-induced DNA damage, although application of a muta-
genic DMBA metabolite resulted in DNA damage levels com-
parable to those in control mice, indicating that LCs are critical 
for the metabolism of DMBA to its mutagenic form. In agree-
ment with these findings, reduced tumorigenesis was observed 
following DMBA treatment of LC-deficient mice; however, 
treatment with a DMBA mutagenic metabolite resulted in 
tumor development at comparable levels in the LC-deficient 
and control animals. These interesting results suggest that resi-
dent tissue-scavenging dendritic cells may enhance mutations 
and tumor development via metabolism of PAHs, which are 
potent carcinogens prevalent in industrial pollution. (Science 
335:104–8, 2012) Selected by P. Bergstresser
Defining touch
Despite years of investigation, the mechanisms by which the 
individual qualities of a sensory stimulus are extracted, inte-
grated, and processed within the central nervous system are 
still unknown. Li and colleagues recently employed molecular–
genetic labeling and somatotopic retrograde tracing to explore 
the organization of peripheral and central axonal endings of 
the low-threshold mechanosensory receptor (LTMR) subtypes. 
Each hair follicle type (guard, Awl/auchene, and Zigzag) in hairy 
mouse skin was found to be innervated by a unique combination 
of the Aβ-, Aδ-, and C-LTMRs. Thus, each of these hair follicles 
represents a physiologically distinct mechanosensory end organ. 
The central projections of the Aβ-, Aδ-, and C-LTMRs that inner-
vate a common peripheral LTMR unit align in a columnar man-
ner in the spinal cord dorsal horn. Together, these findings shed 
light on the mechanisms that enable the skin mechanosensory 
system to convey the complex combinations of qualities that 
define touch. (Cell 147:1615–27, 2011) Selected by G. Cotsarelis
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